Clinical Trials Browser

Adenocarcinoma, Rectal Neoplasms

NCT06915909 2025-04-08

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Phase NA Not yet recruiting

40 enrolled

Genitourinary

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

NCT00614211 2023-04-18

LACC

Phase NA Completed

636 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Uterine Cervical Neoplasms, Neoplasms

NCT00096408 2019-03-20

Laparoscopic Approach to Cancer of the Endometrium

Phase 3 Completed

760 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Neoplasms, Endometrial Neoplasms

NCT01952951 2017-09-13

PREPARE

Phase 2 Unknown

110 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT02741778 2016-04-18

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Phase NA Unknown

120 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Phase 2 Unknown

162 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

315 enrolled

Thoracic

Adenocarcinoma, Lung Neoplasms

NCT01037998 2009-12-23

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Phase 2 Completed

115 enrolled

Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

Clinical Trials

NOAHS-ARC

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

LACC

Laparoscopic Approach to Cancer of the Endometrium

PREPARE

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer